Literature DB >> 19095325

Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats.

Niloofar M Tabatabai1, Mukut Sharma, Samuel S Blumenthal, David H Petering.   

Abstract

Diabetes-mediated changes in mRNA expressions of kidney glucose transporters SGLT1 and SGLT2 were investigated in Zucker rats. SGLTs expressions in pre-diabetic obese rats were similar to leans. SGLT1 and SGLT2 levels in diabetic obese rats were 1.6 (P<0.03) and 4.8 (P<0.002) folds higher than age-matched leans, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095325      PMCID: PMC2652566          DOI: 10.1016/j.diabres.2008.11.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  17 in total

1.  Dysregulation of renal salt and water transport proteins in diabetic Zucker rats.

Authors:  Crystal A Bickel; Mark A Knepper; Joseph G Verbalis; Carolyn A Ecelbarger
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

2.  Long-term regulation of renal Na-dependent cotransporters and ENaC: response to altered acid-base intake.

Authors:  G H Kim; S W Martin; P Fernández-Llama; S Masilamani; R K Packer; M A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2000-09

3.  Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat.

Authors:  S Vestri; M M Okamoto; H S de Freitas; R Aparecida Dos Santos; M T Nunes; M Morimatsu; J C Heimann; U F Machado
Journal:  J Membr Biol       Date:  2001-07-15       Impact factor: 1.843

Review 4.  Kidney disease in diabetology: lessons from 2007.

Authors:  Guntram Schernthaner
Journal:  Nephrol Dial Transplant       Date:  2008-04       Impact factor: 5.992

5.  Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium.

Authors:  N M Tabatabai; S S Blumenthal; D L Lewand; D H Petering
Journal:  Toxicol Appl Pharmacol       Date:  2001-12-15       Impact factor: 4.219

6.  HNF1alpha controls renal glucose reabsorption in mouse and man.

Authors:  M Pontoglio; D Prié; C Cheret; A Doyen; C Leroy; P Froguel; G Velho; M Yaniv; G Friedlander
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

7.  Hyperphagia as a mediator of renal disease initiation in obese Zucker rats.

Authors:  F T Stevenson; C M Wheeldon; M D Gades; H van Goor; J S Stern
Journal:  Obes Res       Date:  2001-08

8.  Regulation of the human Na(+)-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1.

Authors:  M G Martín; J Wang; R S Solorzano-Vargas; J T Lam; E Turk; E M Wright
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-04       Impact factor: 4.052

9.  Transcriptional regulation of the ovine intestinal Na+/glucose cotransporter SGLT1 gene. Role of HNF-1 in glucose activation of promoter function.

Authors:  S Vayro; I S Wood; J Dyer; S P Shirazi-Beechey
Journal:  Eur J Biochem       Date:  2001-10

10.  Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension.

Authors:  Rocío Bautista; Rebeca Manning; Flavio Martinez; Maria del Carmen Avila-Casado; Virginia Soto; Armando Medina; Bruno Escalante
Journal:  Am J Physiol Renal Physiol       Date:  2003-09-23
View more
  42 in total

1.  A fluorescence method for measurement of glucose transport in kidney cells.

Authors:  Amy B Blodgett; Rajendra K Kothinti; Ivan Kamyshko; David H Petering; Suresh Kumar; Niloofar M Tabatabai
Journal:  Diabetes Technol Ther       Date:  2011-04-21       Impact factor: 6.118

Review 2.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

3.  Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.

Authors:  Ivan Sabolic; Ivana Vrhovac; Daniela Balen Eror; Maria Gerasimova; Michael Rose; Davorka Breljak; Marija Ljubojevic; Hrvoje Brzica; Anne Sebastiani; Serge C Thal; Christoph Sauvant; Helmut Kipp; Volker Vallon; Hermann Koepsell
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-18       Impact factor: 4.249

Review 4.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

5.  Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm.

Authors:  Dilpreet Singh; Amrit Pal Singh; Drishtant Singh; Anup Kumar Kesavan; Saroj Arora; Ashok K Tiwary; Neena Bedi
Journal:  Daru       Date:  2020-02-07       Impact factor: 3.117

Review 6.  Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.

Authors:  Munehiro Kitada; Yoshio Ogura; Itaru Monno; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

7.  Renal olfactory receptor 1393 contributes to the progression of type 2 diabetes in a diet-induced obesity model.

Authors:  Blythe D Shepard; Hermann Koepsell; Jennifer L Pluznick
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-28

8.  Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats.

Authors:  Naoki Kojima; Jan M Williams; Teisuke Takahashi; Noriyuki Miyata; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2013-03-14       Impact factor: 4.030

Review 9.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 10.  Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.

Authors:  Panai Song; Akira Onishi; Hermann Koepsell; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.